AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON JUNE 17, 2003
Registration No. 333-61430
================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
--------------
POST-EFFECTIVE AMENDMENT NO. 1 TO
FORM S-3
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
THE MEDICINES COMPANY
(Exact name of registrant as specified in its charter)
DELAWARE 04-3324394
(State or other Jurisdiction of (I.R.S. Employer Identification Number)
Incorporation or Organization)
8 CAMPUS DRIVE
PARSIPPANY, NEW JERSEY 07054
(973) 656-1616
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
CLIVE A. MEANWELL
EXECUTIVE CHAIRMAN
THE MEDICINES COMPANY
8 CAMPUS DRIVE
PARSIPPANY, NEW JERSEY 07054
(973) 656-1616
(Name, address, including zip code, and telephone number,
including area code, of agent for service)
WITH A COPY TO:
STUART M. FALBER, ESQ.
HALE AND DORR LLP
60 STATE STREET
BOSTON, MASSACHUSETTS 02109
TELEPHONE: (617) 526-6000
TELECOPY: (617) 526-5000
================================================================================
DEREGISTRATION OF SECURITIES
On June 19, 2001, the Securities and Exchange Commission (the "SEC")
declared effective the registration statement on Form S-1 (File No. 333-61430)
(the "Initial Registration Statement") filed by The Medicines Company (the
"Company") with respect to the resale on a continuous or delayed basis of an
aggregate of 4,000,000 shares of common stock, par value $.001 per share, of the
Company (the "Shares").
The Initial Registration Statement was filed for the benefit of the
holders of Shares (the "Holders") who purchased such Shares in a private
placement (the "Offering") pursuant to Stock Purchase Agreements dated as of May
11, 2001 (collectively, the "Agreements"). The Initial Registration Statement
was converted to Form S-3 by means of a post-effective amendment dated September
5, 2001 (the "Post-Effective Amendment"), which was declared effective by the
SEC on September 7, 2001. The "Registration Statement" referenced below means
the registration statement on Form S-3 resulting from the Post-Effective
Amendment.
The Agreements require the Company to keep the Registration Statement
effective for a period not exceeding, with respect to each Holder's Shares, the
earlier of (i) the second anniversary of the closing date of the Offering, (ii)
the date on which the Holder may sell all Shares then held by the Holder without
restriction by the volume limitations of Rule 144(e) of the Securities Act of
1933, as amended, or (iii) such time as all Shares purchased by such Holder in
the Offering have been sold pursuant to a registration statement. The second
anniversary of the closing date of the Offering occurred on May 16, 2003.
In accordance with the terms of the Agreements, and in accordance with the
Company's undertaking under Regulation S-K Item 512(a)(3), the Company is filing
this Post-Effective Amendment No. 1 to the Registration Statement to remove from
registration all Shares not sold by the Holders pursuant to the Registration
Statement. Accordingly, the Company hereby requests that upon the effectiveness
of this Post-Effective Amendment No. 1, such Shares be removed from
registration.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended,
the Registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form S-3 and has duly caused this
Post-Effective Amendment No. 1 on Form S-3 to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of Parsippany, State of New
Jersey, on June 13, 2003.
THE MEDICINES COMPANY
By: /s/ Steven H. Koehler
------------------------------------------
Steven H. Koehler
Vice President and Chief Financial Officer
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended,
this Post-Effective Amendment No. 1 on Form S-3 has been signed by the following
persons in the capacities and on the dates indicated.
SIGNATURE TITLE DATE
--------- ----- ----
/s/ Clive A. Meanwell Executive Chairman and Chairman of the Board of June 13, 2003
- ------------------------------------ Directors (Principal Executive Officer)
Clive A. Meanwell
/s/ David M. Stack President, Chief Executive Officer and Director June 13, 2003
- ------------------------------------ (Principal Executive Officer)
David M. Stack
/s/ Steven H. Koehler Vice President and Chief Financial Officer June 13, 2003
- ------------------------------------ (Principal Financial and Accounting Officer)
Steven H. Koehler
* Director June 13, 2003
- ------------------------------------
Leonard Bell
- ------------------------------------ Director
William W. Crouse
- ------------------------------------ Director
Robert J. Hugin
* Director June 13, 2003
- ------------------------------------
M. Fazle Husain
SIGNATURE TITLE DATE
--------- ----- ----
/s/ T. Scott Johnson Director June 13, 2003
- ------------------------------------
T. Scott Johnson
- ------------------------------------ Director
Armin M. Kessler
- ------------------------------------ Director
Robert G. Savage
* Director June 13, 2003
- ------------------------------------
James E. Thomas
*By:/s/ Clive A. Meanwell
--------------------------
Clive A. Meanwell
Attorney-in-Fact
Power of Attorney dated May 23, 2001